Literature DB >> 16401756

Analysis of the LRRK2 G2019S mutation in Alzheimer Disease.

Cyrus P Zabetian, Chris J Lauricella, Debby W Tsuang, James B Leverenz, Gerard D Schellenberg, Haydeh Payami.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16401756      PMCID： PMC2824132          DOI： 10.1001/archneur.63.1.156

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  7 in total

1.  Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations.

Authors:  Jennifer Kachergus; Ignacio F Mata; Mary Hulihan; Julie P Taylor; Sarah Lincoln; Jan Aasly; J Mark Gibson; Owen A Ross; Timothy Lynch; Joseph Wiley; Haydeh Payami; John Nutt; Demetrius M Maraganore; Krzysztof Czyzewski; Maria Styczynska; Zbigniew K Wszolek; Matthew J Farrer; Mathias Toft
Journal:  Am J Hum Genet       Date:  2005-02-22       Impact factor: 11.025

2.  LRRK2 mutations are not common in Alzheimer's disease.

Authors:  Mathias Toft; Sigrid Botne Sando; Stacey Melquist; Owen A Ross; Linda R White; Jan O Aasly; Matthew J Farrer
Journal:  Mech Ageing Dev       Date:  2005-11       Impact factor: 5.432

3.  Parkinson's disease and LRRK2: frequency of a common mutation in U.S. movement disorder clinics.

Authors:  Denise M Kay; Cyrus P Zabetian; Stewart A Factor; John G Nutt; Ali Samii; Alida Griffith; Tom D Bird; Patricia Kramer; Donald S Higgins; Haydeh Payami
Journal:  Mov Disord       Date:  2006-04       Impact factor: 10.338

4.  Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12.

Authors:  M A Pericak-Vance; M P Bass; L H Yamaoka; P C Gaskell; W K Scott; H A Terwedow; M M Menold; P M Conneally; G W Small; J M Vance; A M Saunders; A D Roses; J L Haines
Journal:  JAMA       Date:  1997-10-15       Impact factor: 56.272

5.  The dardarin G 2019 S mutation is a common cause of Parkinson's disease but not other neurodegenerative diseases.

Authors:  Dena Hernandez; Coro Paisan Ruiz; Anthony Crawley; Roneil Malkani; John Werner; Katrina Gwinn-Hardy; Dennis Dickson; Fabienne Wavrant Devrieze; John Hardy; Andrew Singleton
Journal:  Neurosci Lett       Date:  2005-12-09       Impact factor: 3.046

6.  Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.

Authors:  Alexander Zimprich; Saskia Biskup; Petra Leitner; Peter Lichtner; Matthew Farrer; Sarah Lincoln; Jennifer Kachergus; Mary Hulihan; Ryan J Uitti; Donald B Calne; A Jon Stoessl; Ronald F Pfeiffer; Nadja Patenge; Iria Carballo Carbajal; Peter Vieregge; Friedrich Asmus; Bertram Müller-Myhsok; Dennis W Dickson; Thomas Meitinger; Tim M Strom; Zbigniew K Wszolek; Thomas Gasser
Journal:  Neuron       Date:  2004-11-18       Impact factor: 17.173

7.  Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease.

Authors:  Coro Paisán-Ruíz; Shushant Jain; E Whitney Evans; William P Gilks; Javier Simón; Marcel van der Brug; Adolfo López de Munain; Silvia Aparicio; Angel Martínez Gil; Naheed Khan; Janel Johnson; Javier Ruiz Martinez; David Nicholl; Itxaso Martí Carrera; Amets Saénz Pena; Rohan de Silva; Andrew Lees; José Félix Martí-Massó; Jordi Pérez-Tur; Nick W Wood; Andrew B Singleton
Journal:  Neuron       Date:  2004-11-18       Impact factor: 17.173
  7 in total
  3 in total

Review 1.  PARK8 LRRK2 parkinsonism.

Authors:  Kristoffer Haugarvoll; Zbigniew K Wszolek
Journal:  Curr Neurol Neurosci Rep       Date:  2006-07       Impact factor: 5.081

2.  Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations.

Authors:  A S Chen-Plotkin; W Yuan; C Anderson; E McCarty Wood; H I Hurtig; C M Clark; B L Miller; V M-Y Lee; J Q Trojanowski; M Grossman; V M Van Deerlin
Journal:  Neurology       Date:  2007-10-03       Impact factor: 9.910

3.  No association between the LRRK2 G2019S mutation and Alzheimer's disease in Italy.

Authors:  Andrea Tedde; Silvia Bagnoli; Elena Cellini; Benedetta Nacmias; Silvia Piacentini; Sandro Sorbi
Journal:  Cell Mol Neurobiol       Date:  2007-09-11       Impact factor: 5.046
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.